Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Entia Biosciences Inc (ERGO)
OTHER OTC:ERGO
Entia Biosciences (ERGO) Financial Statements
6 Followers
Entia Biosciences Financial Overview
| Dec 16 | Sep 16 | Jun 16 | Mar 16 | Dec 15 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 45.99K | $ 41.85K | $ 98.42K | $ 79.20K | $ 68.40K |
| Gross Profit | $ 35.87K | $ 28.43K | $ 62.83K | $ 46.84K | $ 37.33K |
| EBIT | $ -389.18K | $ -274.14K | $ -383.74K | $ -265.20K | $ -273.23K |
| EBITDA | $ -385.69K | $ -269.41K | $ -379.01K | $ -260.46K | $ -266.22K |
| Net Income Common Stockholders | $ -432.78K | $ -288.78K | $ -401.63K | $ -272.59K | $ -303.28K |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 76.05K | $ 2.02K | $ 17.76K | $ 0.00 | $ 24.13K |
| Total Assets | $ 439.14K | $ 365.83K | $ 399.80K | $ 405.77K | $ 448.61K |
| Total Debt | $ 1.05M | $ 552.82K | $ 490.54K | $ 361.51K | $ 279.24K |
| Net Debt | $ 969.95K | $ 550.80K | $ 472.78K | $ 361.51K | $ 255.10K |
| Total Liabilities | $ 2.41M | $ 2.01M | $ 1.79M | $ 1.43M | $ 1.24M |
| Stockholders Equity | $ -1.97M | $ -1.64M | $ -1.39M | $ -1.03M | $ -791.19K |
| Cash Flow | - | ||||
| Free Cash Flow | $ -439.96K | $ -73.61K | $ -104.92K | $ -103.72K | $ -59.95K |
| Operating Cash Flow | $ -439.96K | $ -73.61K | $ -102.33K | $ -99.19K | $ -59.43K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ -2.59K | $ -4.53K | $ -515.00 |
| Financing Cash Flow | $ 513.99K | $ 57.88K | $ 122.68K | $ 79.59K | $ 42.73K |
Entia Biosciences Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.